Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
复制标题
房颤消融治疗肺动脉高压的结果:肺动脉高压是可改变的危险因素吗?
DOI:
10.1016/j.ijcha.2019.100360
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Dobrev,Dobromir
中科院分区:
文献类型:
--
作者:
Linz,Dominik;Dobrev,Dobromir
journal homepage: http://www. journals. elsevier. com/ijc-heart-and-vasculature risk factors such as obesity, hypertension, sleep apnea and metabolic syndrome, which are all associated with systemic inflammation, neurohumoral activation, oxidative stress, hypoxemia, sympathetic excitation and atrial cardiomyopathy (Fig. 1)[12–14]. Thus, a more detailed characterization and assessment of the severity of PH in AF patients may help to better identify patients at risk. Whether PH is a modifiable risk factor or rather a marker of underlying disease predisposing to acute kidney injury after AF ablation warrants further prospective study.